Showing results (201-210 of 245) with videos related to

Sort By:
Pageof 25
International Journal of MS Care|December 21, 2018
Evaluation of a Novel Preference Assessment Tool for Patients with Multiple SclerosisNananda F Col, Andrew J Solomon, Vicky Springmann, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|May 12, 2018
Fingolimod's Impact on MRI Brain Volume Measures in Multiple Sclerosis: Results from MS-MRIUSRobert Zivadinov, Jennie Medin, Nasreen Khan, et al.
Scientific Reports|May 16, 2026
The relationship between objective and subjective cognitive performance and clinical and MRI disease burden in early multiple sclerosisDelphine Van Laethem, Lars Costers, Augusto Miravalle, et al.
Frontiers in Immunology|June 15, 2026
Disease outcomes with ublituximab in treatment-naïve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosisDerrick Robertson, Enrique Alvarez, Lawrence Steinman, et al.
Journal of Neurology|September 13, 2012
Role of magnetic resonance imaging, cerebrospinal fluid, and electroencephalogram in diagnosis of sporadic Creutzfeldt-Jakob diseaseLeo H Wang, Robert C Bucelli, Erica Patrick, et al.
JAMA Neurology|February 16, 2026
Five Years of Ublituximab in Multiple Sclerosis: ULTIMATE I and II Open-Label Extension StudyBruce A C Cree, Edward Fox, Hans-Peter Hartung, et al.
Frontiers in Public Health|June 10, 2024
Mathematical modeling of SARS-CoV-2 variant substitutions in European countries: transmission dynamics and epidemiological insightsVíctor López de Rioja, Aida Perramon-Malavez, Sergio Alonso, et al.
Frontiers in Public Health|August 29, 2022
Transmissibility, hospitalization, and intensive care admissions due to omicron compared to delta variants of SARS-CoV-2 in Catalonia: A cohort study and ecological analysisMartí Català, Ermengol Coma, Sergio Alonso, et al.
Frontiers in Immunology|April 18, 2022
Prognostic Value of Serum Neurofilament Light Chain for Disease Activity and Worsening in Patients With Relapsing Multiple Sclerosis: Results From the Phase 3 ASCLEPIOS I and II TrialsTjalf Ziemssen, Douglas L Arnold, Enrique Alvarez, et al.
Frontiers in Public Health|February 6, 2023
Corrigendum: Transmissibility, hospitalization, and intensive care admissions due to omicron compared to delta variants of SARS-CoV-2 in Catalonia: A cohort study and ecological analysisMartí Català, Ermengol Coma, Sergio Alonso, et al.
Pageof 25